Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02760160
What this trial is testing

Dietary Prevention of Photodamage in Skin With Grapes

Who this might be right for
Non-melanoma Skin Cancer
University of Alabama at Birmingham 18
Early research (Phase 1)Active Not RecruitingNCT05068102
What this trial is testing

Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck (HNSCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Boehringer Ingelheim 14
Not applicableAvailableNCT04853602
What this trial is testing

IFx-Hu2.0 Expanded Access Program

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IVMerkel Cell Carcinoma+1 more
TuHURA Biosciences, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT06237881
What this trial is testing

KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMelanomaLung Neoplasms+1 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00021164
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Not applicableStudy completedNCT06654999
What this trial is testing

How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions.

Who this might be right for
Skin CancerMelanoma of SkinSquamous Cell Cancer+1 more
Skin Analytics Limited 115
Testing effectiveness (Phase 2)Study completedNCT00602199
What this trial is testing

ABT-510 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 42
Testing effectiveness (Phase 2)Study completedNCT00080353
What this trial is testing

Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT01248936
What this trial is testing

RO5185426 in Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 374
Early research (Phase 1)UnknownNCT04357509
What this trial is testing

The Tolerance,Pharmacokinetic Characteristics,Safety and Efficacy of ScTIL210 in the Treatment of Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 32
Not applicableStudy completedNCT00928031
What this trial is testing

Long-term Data Collection for Subjects in MDX-010 Studies

Who this might be right for
Metastatic Melanoma
Bristol-Myers Squibb 160
Testing effectiveness (Phase 2)Study completedNCT02537600
What this trial is testing

Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis

Who this might be right for
Malignant Melanoma
Center Eugene Marquis 43
Not applicableStudy completedNCT00506311
What this trial is testing

Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT01636882
What this trial is testing

CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext)

Who this might be right for
Melanoma
Viralytics 16
Testing effectiveness (Phase 2)Study completedNCT00462423
What this trial is testing

Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study

Who this might be right for
Metastatic Malignant Melanoma
Lynn E. Spitler, MD 50
Not applicableStudy completedNCT06189261
What this trial is testing

Holistic Needs Assessments in Patients With Melanoma

Who this might be right for
MelanomaUnsatisfied Needs
University of Surrey 30
Testing effectiveness (Phase 2)Study completedNCT01266603
What this trial is testing

High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 44
Not applicableUnknownNCT04485442
What this trial is testing

Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face

Who this might be right for
Skin Cancer
University Hospital, Basel, Switzerland 100
Not applicableEnrolling By InvitationNCT05212103
What this trial is testing

PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9

Who this might be right for
Acute Myeloid LeukemiaMelanomaNon Small Cell Lung Cancer
Turku University Hospital 30
Early research (Phase 1)Ended earlyNCT02097225
What this trial is testing

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Malignant Solid Neoplasm+7 more
National Cancer Institute (NCI) 22
Next Page